克罗辛通过调节AKT1来预防烟雾引起的慢性阻塞性肺病
Yuehong Zhu1,2, Yuntao Jiang1,3, Jieping Xu1,3
1Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, China.
Frontiers in pharmacology
|February 25, 2026
概括
克罗辛通过减少炎症和调节AKT1.1,显示了慢性阻塞性肺病 (COPD) 的治疗潜力. 这项研究使用多维方法验证了它的效果,克服了潜在的非特异性化合物活性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 慢性阻塞性肺病 (COPD) 涉及呼吸道炎症和重塑,需要新的治疗点.
- 克罗辛 (Crocin) 来自沙夫兰,具有潜在的治疗益处,但可能具有类似泛试验干扰化合物 (PAINS) 的特性,使解释复杂化.
- 一个多维的策略至关重要,以验证crocin在COPD的影响.
研究的目的:
- 为了确定与COPD相关的crocin的分子标.
- 在COPD模型中研究素的治疗效果.
- 为了验证crocin的作用机制,考虑到潜在的PINS特性.
主要方法:
- 网络分析发现了crocin和COPD之间的共同目标.
- 分子对接和动力学模拟评估了crocin-target相互作用.
- 在体外 (CETSA) 和体内 (老鼠模型) 实验中评估了crocin的疗效和机制.
主要成果:
- 网络分析预测了48个共同目标,突出了PI3K-AKT途径.
- 克罗辛对AKT1具有良好的结合,由分子动力学和CETSA证实.
- 在体内研究中,在COPD小鼠模型中证明了crocin的抗炎作用和AKT1的调节.
结论:
- 克罗辛通过抗炎作用和AKT1调节对COPD具有治疗潜力.
- 综合网络,体外和体内数据支持crocin的生物相关性.
- 这项研究提供了可靠的验证crocin的效果,减轻了有关PAINS属性的担忧.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.9K
COPD: Pathogenesis and Clinical Features
2.0K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K
Chronic Obstructive Pulmonary Disease
2.7K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
COPD: Management Using Bronchodilators and Corticosteroids
942
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
942
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K


